iiinova — where your digital self keeps evolving

Claire Friedemann Smith @clairefriedsmith.bsky.social · 03/07/2026

First paper of the MODE study out today! We explored how interim non-cancer diagnoses might impact cancer diagnoses from the view point of HCPs, patients, and in terms of cost, time to diagnosis and disease stage. This first paper describes our HCP interview findings. Lots more to come soon!

000

Claire Friedemann Smith @clairefriedsmith.bsky.social · 09/10/2025

A brilliant paper from my brilliant friend, colleague and desk buddy, Kiana Collins. PSA testing may not be being received by those who are most likely to benefit, and may be overused in those less likely to benefit.

001

Claire Friedemann Smith @clairefriedsmith.bsky.social · 15/05/2025

In a world where GP is bashed, a lot, @timsenior.bsky.social finds the value bjgp.org/content/75/7... This line in particular got me: The consultations I have had with these patients aren’t consultations of 15 or 30 minutes. They are consultations of 2, 5, 10 years, split up into 15-minute chunks.

bjgp.org

123

Claire Friedemann Smith @clairefriedsmith.bsky.social · 30/04/2025

Good bye sunny Manchester and the always brilliant #CaPRI2025. Already looking forward to next year.

020

Claire Friedemann Smith @clairefriedsmith.bsky.social · 29/04/2025

Ever used the Aarhus Statement in your cancer in primary care research? I'm pleased to be part of the team aiming to update it, if you are asked to complete the Delphi please do consider contributing and stay tuned! #CaPRI2025

010

Claire Friedemann Smith @clairefriedsmith.bsky.social · 29/04/2025

Truly fascinating and sobering keynote talk from Prof Richard Sullivan to kick off #CaPRI2025 on the future of global cancer care. Global public health is changing, hopefully for the better but the challenge is enormous.

021

Claire Friedemann Smith @clairefriedsmith.bsky.social · 28/04/2025

Hi Bluesky! So excited to be in Manchester for the #CaPRI2025 cancer in primary care conference

081